NHC Reports Director, Officer, and Compensation Changes
Ticker: NHC · Form: 8-K · Filed: Sep 26, 2025 · CIK: 1047335
Sentiment: neutral
Topics: management-change, corporate-governance, filing
TL;DR
NHC filed an 8-K on 9/26 for 9/23 events: director/officer changes & comp arrangements.
AI Summary
National Healthcare Corporation (NHC) filed an 8-K on September 26, 2025, reporting events that occurred on September 23, 2025. The filing indicates changes related to the departure or election of directors, appointment of officers, and compensatory arrangements for certain officers. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
Changes in corporate leadership and compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially if numerous or related to compensation, can introduce uncertainty about future strategy and stability.
Key Numbers
- 20250923 — Event Date (Date of earliest event reported)
- 20250926 — Filing Date (Date the report was filed with the SEC)
Key Players & Entities
- NATIONAL HEALTHCARE CORP (company) — Registrant
- 0001047335 (company) — Central Index Key
- 522057472 (company) — EIN
- Delaware (company) — State of Incorporation
FAQ
What specific changes occurred regarding directors or officers on September 23, 2025?
The filing indicates events related to the departure of directors or certain officers, election of directors, and appointment of certain officers.
Were there any changes to compensatory arrangements for officers?
Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure.
What is the primary business of National Healthcare Corporation?
National Healthcare Corporation operates in the SERVICES-SKILLED NURSING CARE FACILITIES sector, SIC code 8051.
When was this 8-K filing submitted to the SEC?
The filing was submitted on September 26, 2025.
Does this filing include any financial statements?
Yes, the filing lists 'Financial Statements and Exhibits' as an item of information.
Filing Stats: 641 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2025-09-26 16:34:33
Key Financial Figures
- $0.1 — nge on which registered Common Stock , $0.1 par value NHC NYSE American Indicat
Filing Documents
- nhc20250926_8k.htm (8-K) — 30KB
- ex_864736.htm (EX-99.1) — 8KB
- 0001437749-25-029946.txt ( ) — 169KB
- nhc-20250923.xsd (EX-101.SCH) — 3KB
- nhc-20250923_def.xml (EX-101.DEF) — 11KB
- nhc-20250923_lab.xml (EX-101.LAB) — 15KB
- nhc-20250923_pre.xml (EX-101.PRE) — 11KB
- nhc20250926_8k_htm.xml (XML) — 3KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 23, 2025, R. Michael Ussery, the Company's President and Chief Operating Officer, notified the Company that he intends to retire from the Company effective December 31, 2025. The decision of Mr. Ussery to retire did not involve any disagreement with the Company. Mr. Ussery has been with the Company since 1980. During his tenure, he has served as Senior Vice President-Operations, Senior Vice President-Central Region, and as Regional Vice President. Mr. Ussery has also served as the Administrator in multiple of the Company's facilities and was the Administrator of the Year in 1989. On January 1, 2009, Mr. Ussery was appointed as the Chief Operating Officer. He was appointed President on January 1, 2017, and has served as both President and Chief Operating Officer since that time and will continue to serve in those roles through his retirement.
01
Item 7.01 Regulation FD Disclosure On September 26, 2025, NHC issued a press release announcing the officer retirement described in Item 5.02 above. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-k. Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Number Exhibit 99.1 Press Release Dated September 26, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 26, 2025 NATIONAL HEALTHCARE CORPORATION By: /s/ Stephen F. Flatt Name: Stephen F. Flatt Title: Chief Executive Officer